Answers are grounded in this paper and cite their sources.
The clinical era of continuous-flow left ventricular assist devices has debunked many myths about the dire need of a pulse for human existence. While this therapy has been documented to provide a clear survival benefit in end-stage heart failure patients, we are now faced with certain morbidity challenges that as of yet have no easy mechanistic physiological explanation. The effect of physiological changes on end-organ function in patients supported by continuous-flow ventricular assist devices may offer insight into some of these morbidities. We therefore present a review of current evidence documenting the impact of continuous flow on end-organ function.
No takes yet. Share an insight, caveat, or question.
Bhimaraj et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: